SQUAWK/NEWS
Menu
Live News EQUITY L impact

Kailera Therapeutics 8-K filing

Kailera Therapeutics reports results of operations and financial condition. Filing includes financial statements and exhibits.

KAIL

Filed: 2026-05-26 AccNo: 0001193125-26-239362 Size: 375 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits